Companies

See how salaries can vary from company to company

Primavera Systems, Inc was a private company providing Project Portfolio Management (PPM) software to help project-intensive organizations identify, prioritize, and select project investments and plan, manage, and control projects and project portfolios of all sizes. On January 1, 2009 Oracle Corporation took legal ownership of Primavera. Joel Koppelman, Les Seskin and Dick Faris founded Primavera Systems, Inc. on May 1, 1983. It traded as a private company based in Pennsylvania (USA), developing software for the Project Portfolio Management market. To help expand its product capabilities, Pr... view company details

Hill International, Inc. provides project and construction management, and other consulting services primarily for the buildings, transportation, environmental, energy, and industrial markets. The company offers program management, project management, construction management, project management oversight, troubled project turnaround, staff augmentation, project labor agreement consulting, commissioning, estimating and cost management, and labor compliance and facilities management services. It primarily serves the United States federal, state and local governments, as well as other national go... view company details

Rare Element Resources Ltd. explores for mineral properties in the United States. It holds a 100% interest in the Bear Lodge property that comprises the Bear Lodge REE project and the Sundance Gold project located in central Crook County, northeast Wyoming. Rare Element Resources Ltd. is headquartered in Littleton, Colorado. view company details

AfterMaster, Inc., together with its subsidiaries, operates as an audio technology company in the United States. It develops and commercializes proprietary audio and video technologies for professional and consumer use. The company offers AfterMaster audio, a mastering, remastering, and audio processing technology that makes various audio source sounds louder, fuller, deeper, and clearer; ProMaster, an online music mastering, streaming, and storage service designed for independent artists; and Aftermaster Pro, a personal audio re-mastering device. It also provides Aftermaster Studio Pro and My... view company details

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with locally advanced or metastatic breast cancer. The company was founded in 2013 and is based in San Diego, California. view company details

Capstone provides project management, construction management and project control services. view company details

Axsome Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing novel therapies for central nervous system (CNS) disorders in the United States. Its product pipeline includes AXS-05, which is in the Phase III clinical trial for the treatment resistant depression; Phase II/III clinical trials in agitation associated with Alzheimer's disease; and Phase II clinical trial for the treatment of smoking cessation, as well as for major depressive disorder. The company is also developing AXS-07, which is in Phase III clinical trial for the treatment of migraine; AXS-12 that... view company details

Ardelyx, Inc., a specialized biopharmaceutical company, develops and sells medicines for the treatment of cardio renal diseases in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel syndrome with constipation, as well as in Phase III clinical trial for the treatment of hyperphosphatemia in end-stage renal disease patients on dialysis. It also develops RDX013, a small molecule potassium secretagogue program for the treatment of patients with hyperkalemia. The co... view company details

We are a technology company that develops innovative solutions in Communications, Computing, and Cyber. Recognized internationally for our innovative solutions and unparalleled engineering expertise, we are committed to changing the world through innovation. Change is the heart of innovation, and disruptive approaches to solving problems enhance the opportunity for change. Through innovation and optimization, we have the ability to discover and maximize advantages for our clients. We engineer solutions to deliver unparalleled advantages in the most powerful way. We enable change. Our technolog... view company details

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing RNA interference (RNAi) therapeutics. The company's pipeline of investigational RNAi therapeutics focus on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system/ocular diseases. It provides ONPATTRO (patisiran), a lipid complex injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. The company's development programs include Vutrisiran, an investigational RNAi therapeutic targeti... view company details

Solitario Zinc Corp., an exploration stage company, engages in the acquisition, exploration, and development of zinc properties in North and South America. It primarily owns a 39% interest in the Florida Canyon zinc project located in northern Peru; and a 50% interest in the Lik zinc-lead-silver property located in Northwest Alaska. The company also owns the La Promesa gold exploration project; and an 85% interest in the Chambara exploration project located in Peru. The company was formerly known as Solitario Exploration & Royalty Corp. and changed its name to Solitario Zinc Corp. in July 2017... view company details

Torchlight Energy Resources, Inc., through its subsidiaries, engages in the acquisition, exploration, exploitation, and/or development of oil and natural gas properties in the United States. As of December 31, 2018, it had interests in four oil and gas projects, including the Orogrande project in Hudspeth County, Texas; Hazel project in Sterling, Tom Green, and Irion Counties, Texas; Winkler project in Winkler County, Texas; and Hunton wells in partnership with Husky Ventures in central Oklahoma. The company was founded in 2010 and is headquartered in Plano, Texas. view company details

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray, which is completed Phase III clinical trials for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. The company was founded in 2007 and is headquartered in Solana Beach, California. view company details

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. It is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases (HIF-PHs) that is in Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States and Europe; and in Phase II/III development in China for anemia associated with myelodysplastic syndromes. The company is also developing Pamrevlumab, a human monoclonal antibody that inhibits the activity of connective tissue ... view company details

Gharafi is a leading engineering firm. We cater to both the public and private sectors. Our most distinguishing characteristic is our criteria for a successful project - No Ghafari project is considered a success until it demonstrates a positive synergy of form and function, fulfills all industry standards and exceeds client expectations. To ensure this success, we draw on the knowledge and specialized experience of our team to provide services throughout the world. Our core competencies include, but are not limited to land planning, site development, due diligence services, utility engineerin... view company details

Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company, develops various antibiotics for the treatment of serious and life-threatening multidrug-resistant infections. The company's lead product candidate is Xerava (eravacycline), a synthetic fluorocycline intravenous and IV antibiotic for use as a first-line empiric monotherapy to treat multidrug-resistant infections, including multidrug-resistant Gram-negative infections. It conducted Phase III clinical trials with Xerava through investigating Gram-negative infections treated with Xerava (IGNITE). The company has completed IGNITE1 and ... view company details

Supernus Pharmaceuticals, Inc., a pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy and migraine. The company's product candidates comprise SPN-812, a viloxazine hydrochloride, which is in Phase III clinical trial that is used for the treatment of attention deficit hyperactivity disorder (ADHD); SPN-8... view company details

Daybreak Oil and Gas, Inc. operates as an independent crude oil and natural gas exploration, development, and production company in the United States. It holds interests in the East Slopes project located in the southeastern part of the San Joaquin Basin near Bakersfield, California. The company also holds a 30% working interest in the Michigan Basin project covering 1,400 acres area. As of February 28, 2018, it had estimated proved reserves of 428,067 barrels of oil equivalent. The company was formerly known as Daybreak Mines, Inc. and changed its name to Daybreak Oil and Gas, Inc. in October... view company details

LRAD Corporation designs, develops, and commercializes directed and multidirectional sound technologies in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It offers voice broadcast products; and location-based mass messaging solutions for emergency warning and workforce management. The company also provides acoustic hailing devices that is used to broadcast project audible voice and tone; and Genasys mass notification that is used to broadcast project audible voice. It sells its products directly to governments, militaries, end-users, and defense-related companies. The com... view company details

Cara Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. Its lead product candidate includes KORSUVA (CR845/ difelikefalin) injection, which is in Phase III clinical trial for the treatment of patients with chronic kidney disease (CKD) associated pruritus undergoing hemodialysis, as well as in Phase II/... view company details